Neil Kumar's Net Worth
Estimate Recalculated Jun 30, 2025 09:50PM EST
Who is Neil Kumar
Neil Kumar has an estimated net worth of $164 Million. This is based on reported shares across multiple companies, which include BridgeBio Pharma, Inc., LianBio, and Eidos Therapeutics, Inc..
SEC CIK
Neil Kumar's CIK is 0001742485
Past Insider Trading and Trends
2021 was Neil Kumar's most active year for acquiring shares with 8 total transactions. Neil Kumar's most active month to acquire stocks was the month of January. 2023 was Neil Kumar's most active year for disposing of shares, totalling 24 transactions. Neil Kumar's most active month to dispose stocks was the month of July. 2021 saw Neil Kumar paying a total of $1,000,000.00 for 1,094,048 shares, this is the most they've acquired in one year. In 2024 Neil Kumar cashed out on 352,660 shares for a total of $4,100,662.79, their largest year based on trade value.
Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Form 4 | -0.36% | -55.54K | $24.64 | -$1.36M | Aug 20, 2024 | 17.34M | Sale | — | Aug 16 - Aug 19 |
Form 4 | -0.55% | -30.75K | $31.04 | -$954.42K | May 17, 2024 | 7.58M | Options | — | May 16 |
Form 4 | — | 358.73K | — | — | Mar 14, 2024 | 358.73K | Grant | — | Mar 12 |
Form 4 | -0.90% | -47.92K | $37.21 | -$1.78M | Feb 21, 2024 | 7.29M | Options | — | Feb 16 |
Form 4 | -1.88% | -102.25K | $28.98 | -$2.96M | Nov 20, 2023 | 7.34M | Sale | Scheduled | Nov 16 - Nov 17 |
Form 4 | -1.85% | -102.25K | $29.19 | -$2.98M | Aug 18, 2023 | 7.44M | Sale | — | Aug 16 - Aug 17 |
Form 4 | -1.81% | -102.25K | $14.05 | -$1.44M | May 18, 2023 | 7.55M | Sale | — | May 16 - May 17 |
Form 4 | -10.59% | -120.00K | $14.18 | -$1.70M | May 05, 2023 | 6.82M | Sale | — | May 03 |
Form 4 | -9.58% | -120.00K | $15.46 | -$1.86M | Apr 07, 2023 | 6.94M | Sale | — | Apr 05 |
Form 4 | -8.74% | -120.00K | $10.96 | -$1.32M | Mar 03, 2023 | 7.06M | Sale | Scheduled | Mar 03 |
Form 4 | -1.33% | -68.71K | $12.68 | -$871.27K | Feb 21, 2023 | 7.47M | Sale | Scheduled | Feb 16 - Feb 17 |
Form 4 | — | 1.16M | — | — | Feb 14, 2023 | 1.16M | Grant | — | Feb 10 |
Form 4 | -8.04% | -120.00K | $11.01 | -$1.32M | Feb 06, 2023 | 7.18M | Sale | Scheduled | Feb 03 |
Form 4 | -7.44% | -120.00K | $7.67 | -$920.86K | Jan 06, 2023 | 7.30M | Sale | Scheduled | Jan 05 |
Form 4 | -16.73% | -200.00K | — | — | Dec 21, 2022 | 7.42M | Sale | — | Dec 21 |
Form 4 | -1.31% | -68.71K | $9.52 | -$654.00K | Nov 18, 2022 | 7.98M | Sale | — | Nov 16 - Nov 17 |
Form 4 | -0.53% | -27.70K | $11.08 | -$306.88K | Aug 18, 2022 | 8.05M | Options | — | Aug 16 |
Form 4 | -0.45% | -23.76K | $6.74 | -$160.14K | May 18, 2022 | 8.08M | Options | — | May 16 |
Form 4 | — | 489.46K | — | — | Mar 18, 2022 | 489.46K | Grant | — | Mar 16 |
Form 4 | -0.06% | -3.08K | $8.84 | -$27.27K | Feb 18, 2022 | 7.61M | Options | — | Feb 16 |
Form 4 | — | 786.07K | — | — | Dec 07, 2021 | 786.07K | Grant | — | Dec 03 |
Form 4 | -0.08% | -3.73K | $47.25 | -$176.24K | Nov 18, 2021 | 7.61M | Options | — | Nov 16 |
Form 4 | -0.08% | -3.73K | $49.48 | -$184.56K | Aug 18, 2021 | 7.62M | Options | — | Aug 16 |
Form 4 | -0.08% | -3.73K | $53.66 | -$200.21K | May 18, 2021 | 7.62M | Options | — | May 16 |
Form 4 | 0.29% | 13.86K | $63.74 | -$138.99K | Feb 18, 2021 | 7.59M | Options | — | Feb 16 - Feb 17 |
Form 4 | — | 264.28K | — | — | Feb 12, 2021 | 264.28K | Grant | — | Feb 10 |
Form 4 | -0.04% | -1.77K | $44.33 | -$78.64K | Nov 18, 2020 | 7.78M | Options | — | Nov 16 |
Form 4 | -0.04% | -1.77K | $28.53 | -$50.61K | Aug 18, 2020 | 7.78M | Options | — | Aug 16 |
Form 4 | -3.69% | -80.00K | $27.23 | -$2.18M | Aug 05, 2020 | 7.70M | Sale | Scheduled | Aug 03 - Aug 04 |
Form 4 | -6.21% | -143.47K | $30.75 | -$4.41M | Jul 06, 2020 | 7.78M | Sale | Scheduled | Jul 01 - Jul 02 |
Form 4 | -0.46% | -10.60K | $30.01 | -$318.13K | Jun 10, 2020 | 7.92M | Sale | Scheduled | Jun 08 |
Form 4 | 28.67% | 666.69K | $30.05 | -$178.17K | Jun 05, 2020 | 8.61M | Grant | Scheduled | Jun 03 |
Form 4 | -3.33% | -80.00K | $29.19 | -$2.34M | Jun 03, 2020 | 7.94M | Sale | Scheduled | Jun 01 |
Form 4 | -3.20% | -79.60K | $31.02 | -$2.47M | May 06, 2020 | 8.02M | Sale | Scheduled | May 05 |
Form 4 | -3.13% | -80.40K | $29.40 | -$2.36M | May 05, 2020 | 8.10M | Sale | Scheduled | May 01 - May 04 |
Form 4 | -0.07% | -1.80K | $25.48 | -$45.98K | Apr 09, 2020 | 8.18M | Sale | Scheduled | Apr 07 |
Form 4 | -0.01% | -300.00 | $25.09 | -$7.53K | Apr 06, 2020 | 8.18M | Sale | Scheduled | Apr 03 |
Form 4 | -2.94% | -77.89K | $26.02 | -$2.03M | Apr 03, 2020 | 8.18M | Sale | Scheduled | Apr 01 - Apr 02 |
Form 4 | -4.34% | -120.00K | $32.28 | -$3.87M | Mar 04, 2020 | 8.26M | Sale | Scheduled | Mar 02 - Mar 03 |
Form 4 | -1.10% | -30.89K | $34.87 | -$1.08M | Feb 07, 2020 | 8.38M | Sale | Scheduled | Feb 05 |
Form 4 | -3.09% | -89.11K | $34.70 | -$3.09M | Feb 05, 2020 | 8.41M | Sale | Scheduled | Feb 03 - Feb 04 |
Form 4 | -3.99% | -120.00K | $32.52 | -$3.90M | Jan 06, 2020 | 8.83M | Sale | Scheduled | Jan 02 - Jan 03 |
Form 4 | — | — | — | — | Jul 03, 2019 | 8.95M | Options | — | Jul 01 |
Form 3 | — | — | — | — | Jun 27, 2019 | — | — | — | — |
Form 3/A | — | — | — | — | Nov 09, 2021 | 5.00M | — | — | — |
Form 3 | — | — | — | — | Oct 29, 2021 | — | — | — | — |
Eidos Therapeutics, Inc.
Form 4 | 3.72% | 882.35K | $29.90 | $26.38M | Jul 08, 2019 | 24.58M | Purchase | — | Jul 03 |
Form 4 | 4.89% | 1.10M | $25.93 | $28.62M | May 29, 2019 | 23.69M | Purchase | — | May 24 |
Form 4 | 24.61% | 3.87M | $17.00 | $13.40M | Jun 22, 2018 | 19.61M | Purchase | — | Jun 22 |
Form 3 | — | — | — | — | Jun 19, 2018 | — | — | — | — |
